Stephen Hall

1.2k total citations
16 papers, 748 citations indexed

About

Stephen Hall is a scholar working on Rheumatology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Stephen Hall has authored 16 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Stephen Hall's work include Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Lipid metabolism and disorders (5 papers) and Systemic Lupus Erythematosus Research (5 papers). Stephen Hall is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Lipid metabolism and disorders (5 papers) and Systemic Lupus Erythematosus Research (5 papers). Stephen Hall collaborates with scholars based in United States, Australia and United Kingdom. Stephen Hall's co-authors include Graham G. Giles, Andrew Forbes, Rachelle Buchbinder, Xenia Dennett, Philippa J. Talmud, Steve E. Humphries, William D. Wallace, Philip R. Greipp, Charles H. Mckenna and Sarah R. Bujac and has published in prestigious journals such as Annals of Internal Medicine, American Journal of Clinical Nutrition and Hepatology.

In The Last Decade

Stephen Hall

16 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Hall United States 13 329 286 186 101 100 16 748
Katherine Bennett Canada 7 88 0.3× 156 0.5× 354 1.9× 121 1.2× 40 0.4× 10 950
Montserrat Miret Switzerland 11 97 0.3× 141 0.5× 42 0.2× 184 1.8× 44 0.4× 13 825
P Oriente Italy 14 78 0.2× 209 0.7× 116 0.6× 111 1.1× 66 0.7× 48 607
Toru Yoshinari Japan 12 95 0.3× 283 1.0× 204 1.1× 376 3.7× 91 0.9× 20 855
Orsolya Tímár Hungary 9 90 0.3× 128 0.4× 83 0.4× 62 0.6× 30 0.3× 10 538
Amal El‐Shehaby Egypt 14 105 0.3× 98 0.3× 100 0.5× 58 0.6× 51 0.5× 24 693
Tomohisa Yamashita Japan 12 76 0.2× 71 0.2× 258 1.4× 63 0.6× 24 0.2× 37 638
Mihaela Taylor United States 12 66 0.2× 688 2.4× 131 0.7× 43 0.4× 31 0.3× 21 985
R. Geer United States 10 275 0.8× 119 0.4× 645 3.5× 189 1.9× 26 0.3× 11 1.3k
E Housset France 14 123 0.4× 61 0.2× 142 0.8× 51 0.5× 31 0.3× 110 652

Countries citing papers authored by Stephen Hall

Since Specialization
Citations

This map shows the geographic impact of Stephen Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Hall more than expected).

Fields of papers citing papers by Stephen Hall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Hall. The network helps show where Stephen Hall may publish in the future.

Co-authorship network of co-authors of Stephen Hall

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Hall. A scholar is included among the top collaborators of Stephen Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Hall. Stephen Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Tanaka, Yoshiya, Tsutomu Takeuchi, Derek Haaland, et al.. (2023). Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post‐hoc analysis of clinical trials. International Journal of Rheumatic Diseases. 26(7). 1248–1259. 8 indexed citations
3.
Stonehouse, Welma, et al.. (2022). Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial. American Journal of Clinical Nutrition. 116(3). 672–685. 47 indexed citations
4.
Friedman, Allon N., Robert Matthew Strother, Sara K. Quinney, et al.. (2010). Measuring the Glomerular Filtration Rate in Obese Individuals without Overt Kidney Disease. Nephron Clinical Practice. 116(3). c224–c234. 33 indexed citations
5.
Hall, Stephen & Patrick Hanrahan. (2005). Muscle Involvement in Mixed Connective Tissue Disease. Rheumatic Disease Clinics of North America. 31(3). 509–517. 13 indexed citations
6.
Wallace, William D., et al.. (2004). Pseudocyst formation in gastric ectopic pancreas.. PubMed. 5(6). 498–501. 61 indexed citations
7.
Buchbinder, Rachelle, Andrew Forbes, Stephen Hall, Xenia Dennett, & Graham G. Giles. (2001). Incidence of Malignant Disease in Biopsy-Proven Inflammatory Myopathy: A Population-Based Cohort Study. Annals of Internal Medicine. 134(12). 1087–1095. 291 indexed citations
8.
Hall, Stephen, Philippa J. Talmud, Derek G. Cook, et al.. (2000). Frequency and allelic association of common variants in the lipoprotein lipase gene in different ethnic groups: The Wandsworth Heart and Stroke Study. Genetic Epidemiology. 18(3). 203–216. 34 indexed citations
9.
10.
Talmud, Philippa J., Stephen Hall, Steve Holleran, et al.. (1998). LPL promoter -93T/G transition influences fasting and postprandial plasma triglycerides response in African-Americans and Hispanics. Journal of Lipid Research. 39(6). 1189–1196. 31 indexed citations
11.
Hall, Stephen, et al.. (1997). A Common Mutation in the Lipoprotein Lipase Gene Promoter, −93T/G, Is Associated With Lower Plasma Triglyceride Levels and Increased Promoter Activity In Vitro. Arteriosclerosis Thrombosis and Vascular Biology. 17(10). 1969–1976. 44 indexed citations
12.
Talmud, Philippa J., et al.. (1997). 76 Lipoprotein lipase −93T/G transition is associated with lower plasma triglyceride levels and increased promoter activity in vitro. Atherosclerosis. 130. S20–S20. 2 indexed citations
13.
Kotowicz, Mark A., Stephen Hall, Gene G. Hunder, et al.. (1990). Relationship of glucocorticoid dosage to serum bone gla‐protein concentration in patients with rheumatologic disorders. Arthritis & Rheumatism. 33(10). 1487–1492. 44 indexed citations
14.
Wood, James R., Albert J. Czaja, Sandra J. Beaver, et al.. (1986). Frequency and significance of antibody to double-stranded DNA in chronic active hepatitis. Hepatology. 6(5). 976–980. 24 indexed citations
15.
Hall, Stephen, et al.. (1985). Splenectomy Does Not Cure the Thrombocytopenia of Systemic Lupus Erythematosus. Annals of Internal Medicine. 102(3). 325–328. 43 indexed citations
16.
Hall, Stephen, et al.. (1984). Systemic Lupus Erythematosus Developing in Patients with Primary Biliary Cirrhosis. Annals of Internal Medicine. 100(3). 388–389. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katherine Bennett Breakdown of academic impact, for papers by Montserrat Miret Breakdown of academic impact, for papers by P Oriente Breakdown of academic impact, for papers by Toru Yoshinari Breakdown of academic impact, for papers by Orsolya Tímár Breakdown of academic impact, for papers by Amal El‐Shehaby Breakdown of academic impact, for papers by Tomohisa Yamashita Breakdown of academic impact, for papers by Mihaela Taylor Breakdown of academic impact, for papers by R. Geer Breakdown of academic impact, for papers by E Housset
Rankless by CCL
2026